Retraction Notice to "Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis" [Neuropharmacology, 107 (2016) 432 - 450]
Neuropharmacology. 2024 May 1;248:109894. doi: 10.1016/j.neuropharm.2024.109894. Epub 2024 Mar 5.NO ABSTRACTPMID:38443226 | DOI:10.1016/j.neuropharm.2024.109894 (Source: Neuropharmacology)
Source: Neuropharmacology - March 5, 2024 Category: Drugs & Pharmacology Authors: Asmaa M Teema Sawsan A Zaitone Yasser M Moustafa Source Type: research
Retraction Notice to "Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis" [Neuropharmacology, 107 (2016) 432 - 450]
Neuropharmacology. 2024 Mar 4:109894. doi: 10.1016/j.neuropharm.2024.109894. Online ahead of print.NO ABSTRACTPMID:38443226 | DOI:10.1016/j.neuropharm.2024.109894 (Source: Neuropharmacology)
Source: Neuropharmacology - March 5, 2024 Category: Drugs & Pharmacology Authors: Asmaa M Teema Sawsan A Zaitone Yasser M Moustafa Source Type: research
Retraction Notice to "Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis" [Neuropharmacology, 107 (2016) 432 - 450]
Neuropharmacology. 2024 Mar 4:109894. doi: 10.1016/j.neuropharm.2024.109894. Online ahead of print.NO ABSTRACTPMID:38443226 | DOI:10.1016/j.neuropharm.2024.109894 (Source: Neuropharmacology)
Source: Neuropharmacology - March 5, 2024 Category: Drugs & Pharmacology Authors: Asmaa M Teema Sawsan A Zaitone Yasser M Moustafa Source Type: research
Retraction Notice to "Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis" [Neuropharmacology, 107 (2016) 432 - 450]
Neuropharmacology. 2024 Mar 4:109894. doi: 10.1016/j.neuropharm.2024.109894. Online ahead of print.NO ABSTRACTPMID:38443226 | DOI:10.1016/j.neuropharm.2024.109894 (Source: Neuropharmacology)
Source: Neuropharmacology - March 5, 2024 Category: Drugs & Pharmacology Authors: Asmaa M Teema Sawsan A Zaitone Yasser M Moustafa Source Type: research
Retraction Notice to "Ibuprofen or piroxicam protects nigral neurons and delays the development of l-dopa induced dyskinesia in rats with experimental Parkinsonism: Influence on angiogenesis" [Neuropharmacology, 107 (2016) 432 - 450]
Neuropharmacology. 2024 Mar 4:109894. doi: 10.1016/j.neuropharm.2024.109894. Online ahead of print.NO ABSTRACTPMID:38443226 | DOI:10.1016/j.neuropharm.2024.109894 (Source: Neuropharmacology)
Source: Neuropharmacology - March 5, 2024 Category: Drugs & Pharmacology Authors: Asmaa M Teema Sawsan A Zaitone Yasser M Moustafa Source Type: research
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review
AbstractField cancerization theory highlights that the skin surrounding actinic keratoses (AK) is also at increased risk for possible malignant transformation; thus, field-directed treatments may both reduce the risk of AK recurrence and potentially reduce the risk of development of cutaneous squamous cell carcinoma (cSCC). Photodynamic therapy (PDT) with either aminolevulinic acid (ALA) or methylaminolevulinate (MAL), as well as topical treatments such as 5-fluorouracil (5-FU), diclofenac gel, piroxicam, imiquimod, and ingenol mebutate, have all shown higher efficacy than vehicle treatments. PDT is widely recognized for i...
Source: American Journal of Clinical Dermatology - February 13, 2024 Category: Dermatology Source Type: research
Clinical implications and future prospects of levonorgestrel and piroxicam as a combined emergency contraceptive regimen
Int J Clin Pharmacol Ther. 2024 Feb 8. doi: 10.5414/CP204537. Online ahead of print.NO ABSTRACTPMID:38329915 | DOI:10.5414/CP204537 (Source: International Journal of Clinical Pharmacology and Therapeutics)
Source: International Journal of Clinical Pharmacology and Therapeutics - February 8, 2024 Category: Drugs & Pharmacology Authors: Jiawei Ke Jingrui Cai Xiaolin Liu Liwen Chen Tianhui Liu Zhipeng Ruan Chengfei Zhao Source Type: research
Clinical implications and future prospects of levonorgestrel and piroxicam as a combined emergency contraceptive regimen
Int J Clin Pharmacol Ther. 2024 Feb 8. doi: 10.5414/CP204537. Online ahead of print.NO ABSTRACTPMID:38329915 | DOI:10.5414/CP204537 (Source: Clinical Pharmacology and Therapeutics)
Source: Clinical Pharmacology and Therapeutics - February 8, 2024 Category: Drugs & Pharmacology Authors: Jiawei Ke Jingrui Cai Xiaolin Liu Liwen Chen Tianhui Liu Zhipeng Ruan Chengfei Zhao Source Type: research
Clinical implications and future prospects of levonorgestrel and piroxicam as a combined emergency contraceptive regimen
Int J Clin Pharmacol Ther. 2024 Feb 8. doi: 10.5414/CP204537. Online ahead of print.NO ABSTRACTPMID:38329915 | DOI:10.5414/CP204537 (Source: International Journal of Clinical Pharmacology and Therapeutics)
Source: International Journal of Clinical Pharmacology and Therapeutics - February 8, 2024 Category: Drugs & Pharmacology Authors: Jiawei Ke Jingrui Cai Xiaolin Liu Liwen Chen Tianhui Liu Zhipeng Ruan Chengfei Zhao Source Type: research
